Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells
- 28 August 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 296 (5) , 1356-1365
- https://doi.org/10.1016/s0006-291x(02)02084-3
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Effects of diabetes and hypertension on glomerular transforming growth factor-β receptor expressionKidney International, 2000
- TGF-β receptor expression and binding in rat mesangial cells: Modulation by glucose and cyclic mechanical strainKidney International, 1999
- Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathwaysJournal of Clinical Investigation, 1999
- Transforming Growth Factor-β1 Stimulates Protein Kinase A in Mesangial CellsJournal of Biological Chemistry, 1998
- Human Smad3 and Smad4 Are Sequence-Specific Transcription ActivatorsPublished by Elsevier ,1998
- High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells.Journal of Clinical Investigation, 1998
- Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cellsProceedings of the National Academy of Sciences, 1997
- Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.Journal of Clinical Investigation, 1997
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose.Journal of Clinical Investigation, 1989